1. New predictive biomarker of response to cetuximab in metastatic colorectal cancer patients
2. Predictive biomarker of response to combination therapy in metastatic colorectal cancer patients
3. Endocan as a serum biomarker of sepsis
4. Gene expression markers for diagnosis and prognosis of lung cancer
5. BRCA Ashkenazi mutation specific antibody test for breast cancer
6. BRCA tissue truncation test for the diagnosis of breast cancer
Tuesday, February 21, 2012
Recent Oncology Biomarker Patents
Highlights of recent US patent applications on cancer biomarkers.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment